Literature DB >> 19036640

Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients.

Alfredo Mendrone1, Cyntia Araujo Arrais, Rosaura Saboya, Dalton de Alencar Fischer Chamone, Frederico Luiz Dulley.   

Abstract

We reviewed the data of 307 patients treated with autologous bone marrow transplantation with the aim to identify factors associated with poor hematopoietic stem cell (HSC) mobilization after administration of cyclophosphamide and granulocyte-colony stimulating factor. Success in mobilization was defined when > or = 2.0 x 10(6) CD34+ cells/kg weight could be collected with < or = 3 leukapheresis procedures. Success was observed in 260 patients (84.7%) and nonsuccess in 47 patients (15.3%). According to the stepwise regression model: diagnosis, chemotherapy load, treatment with mitoxantrone and platelet count before mobilization were found to be independent predictive factors for HSC mobilization. These results could help in the previous recognition of patients at risk for non response to mobilization and allow to plan an alternative protocol for this group of patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036640     DOI: 10.1016/j.transci.2008.09.012

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  7 in total

Review 1.  Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation.

Authors:  M Mohty; K Hübel; N Kröger; M Aljurf; J Apperley; G W Basak; A Bazarbachi; K Douglas; I Gabriel; L Garderet; C Geraldes; O Jaksic; M W Kattan; Z Koristek; F Lanza; R M Lemoli; L Mendeleeva; G Mikala; N Mikhailova; A Nagler; H C Schouten; D Selleslag; S Suciu; A Sureda; N Worel; P Wuchter; C Chabannon; R F Duarte
Journal:  Bone Marrow Transplant       Date:  2014-03-31       Impact factor: 5.483

2.  Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent.

Authors:  Liuyan Jiang; Sunny Malik; Mark Litzow; Dennis Gastineau; Ivana Micallef; Vivek Roy; Lawrence Solberg; Abba C Zubair
Journal:  Transfusion       Date:  2011-08-09       Impact factor: 3.157

3.  Platelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection Result.

Authors:  Marc-Andrea Baertsch; Katharina Kriegsmann; Petra Pavel; Thomas Bruckner; Michael Hundemer; Mark Kriegsmann; Anthony D Ho; Hartmut Goldschmidt; Patrick Wuchter
Journal:  Transfus Med Hemother       Date:  2017-10-04       Impact factor: 3.747

4.  Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo.

Authors:  A Olivieri; M Marchetti; R Lemoli; C Tarella; A Iacone; F Lanza; A Rambaldi; A Bosi
Journal:  Bone Marrow Transplant       Date:  2011-05-30       Impact factor: 5.483

Review 5.  Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility.

Authors:  Olivier Hequet
Journal:  J Blood Med       Date:  2015-02-18

6.  Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma

Authors:  Haluk Demiroğlu; Rafiye Çiftçiler; Yahya Büyükaşık; Hakan Göker
Journal:  Turk J Haematol       Date:  2020-11-09       Impact factor: 1.831

7.  Analysis of the feasibility of early hospital discharge after autologous hematopoietic stem cell transplantation and the implications to nursing care.

Authors:  Alessandra Barban; Fabio Luiz Coracin; Priscila Tavares Musqueira; Andrea Barban; Lilian Piron Ruiz; Milton Artur Ruiz; Rosaura Saboya; Frederico Luiz Dulley
Journal:  Rev Bras Hematol Hemoter       Date:  2014-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.